Umlas J, Turner L A
Blood Bank, Mount Auburn Hospital, Cambridge, Massachusetts.
Transfusion. 1993 Aug;33(8):686-8. doi: 10.1046/j.1537-2995.1993.33893342753.x.
When a patient's serum contains a temperature-independent antibody reacting with all antibody screening and antibody identification panel cells but with few or no units of blood used for crossmatching, one should suspect an antibody against a constituent of the suspension medium of the reagent blood cells. This observation is confirmed by negative reactions with a) washed reagent cells or b) another manufacturer's cells that do not contain the same additives. Two patients are described with antibodies to hydrocortisone that are present in one manufacturer's antibody screening cells and identification panels. The hydrocortisone was added by the manufacturer to prevent hemolysis of the reagent red cells. The patient's antibodies were IgM, complement independent, and nonneutralizable by prior incubation with hydrocortisone. The addition of hydrocortisone to other manufacturers' reagents converted previously negative reactions to the same level of positivity as was seen with the reagent from the index manufacturer. Antibodies to reagent constituents can cause delays in finding compatible blood. It is suggested that manufacturers delete irrelevant additives or those of questionable necessity from their reagents.
当患者血清中含有一种与所有抗体筛查和抗体鉴定细胞板细胞发生反应的温度非依赖性抗体,但用于交叉配血的血液单位很少或没有反应时,应怀疑存在针对试剂血细胞悬浮介质成分的抗体。通过以下方法的阴性反应可证实这一观察结果:a)洗涤后的试剂细胞;b)另一家制造商的不含有相同添加剂的细胞。本文描述了两名患者,其血清中存在针对氢化可的松的抗体,该抗体存在于一家制造商的抗体筛查细胞和鉴定细胞板中。氢化可的松是由制造商添加的,用于防止试剂红细胞溶血。患者的抗体为IgM,不依赖补体,且预先与氢化可的松孵育不能使其中和。将氢化可的松添加到其他制造商的试剂中,可使先前的阴性反应转变为与索引制造商试剂相同程度的阳性反应。针对试剂成分的抗体可导致寻找相容血液的延迟。建议制造商从其试剂中删除无关的添加剂或必要性存疑的添加剂。